Restart Life Sciences Corp NMLSF
Trading Information
- Previous Close Price
- $0.07
- Day Range
- $0.05–0.05
- 52-Week Range
- $0.01–0.12
- Bid/Ask
- $0.05 / $0.09
- Shares Outstanding
- 61.33M
- Market Cap
- $2.89M
- Volume/Avg
- 2,025 / 3,438
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 20.66
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Restart Life Sciences Corp is a Canadian-based life sciences company dedicated to addressing health challenges with wellness solutions. Its brands include HolyCrap, BrainQ, Brain Balls.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- —
- Website
- https://www.restartlife.co
Valuation
|
Metric
|
NMLSF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 2.60 |
Price/Sales | 20.66 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
NMLSF
|
|---|---|
Quick Ratio | 1.75 |
Current Ratio | 2.01 |
Interest Coverage | — |
Quick Ratio
NMLSF
Profitability
|
Metric
|
NMLSF
|
|---|---|
Return on Assets (Normalized) | −86.75% |
Return on Equity (Normalized) | −141.08% |
Return on Invested Capital (Normalized) | −117.66% |
Return on Assets
NMLSF
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|>lN^Vk | LOCK|$pFsq | $133B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|hv?#PYq | LOCK|tvbkl | $83B | |||
| argenx SE ADR
ARGX
| LOCK|hWGV?K? | LOCK|qlw | $55B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|#WP<fyzt | LOCK|NzWJN | $51B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|&Qjm@zm | LOCK|?G | $42B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|HChs%Y | LOCK|CdFgl | $29B | |||
| Incyte Corp
INCY
| LOCK|XMVZd#t | LOCK|&q% | $25B | |||
| Moderna Inc
MRNA
| LOCK|$P!&<Kk | LOCK|>% | $24B | |||
| BioNTech SE ADR
BNTX
| LOCK|!NnnTrQ | LOCK|h<b | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|nvgp#q | LOCK|%^ | $17B |
United States